Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: L2 DIAGNOSTICS LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2025-08-01 to 2027-07-31
Current total value of award: $599471
Description: THERAPEUTIC VACCINE PLATFORM TO BOOST IMMUNE RESPONSES IN TUBERCULOSIS